Nemotron-Labs-Diffusion 3B vs ShieldGemma 9B
Nemotron-Labs-Diffusion 3B (2026) and ShieldGemma 9B (2024) are compact production models from NVIDIA AI and Google DeepMind. Nemotron-Labs-Diffusion 3B ships a 131k-token context window, while ShieldGemma 9B ships a 8k-token context window. This comparison covers specs, pricing, API access, capabilities, benchmarks, input and output token costs, and production fit for coding and agent workloads. It focuses on practical selection signals rather than broad model-family marketing.
Nemotron-Labs-Diffusion 3B fits 16x more tokens; pick it for long-context work and ShieldGemma 9B for tighter calls.
Decision scorecard
Local evidence first| Signal | Nemotron-Labs-Diffusion 3B | ShieldGemma 9B |
|---|---|---|
| Best for | general production evaluation | general production evaluation |
| Decision fit | Long context | Classification |
| Context window | 131k | 8k |
| Cheapest output | - | - |
| Provider routes | 0 tracked | 1 tracked |
| Shared benchmarks | 0 shared | 0 shared |
Decision tradeoffs
- Nemotron-Labs-Diffusion 3B has the larger context window for long prompts, retrieval packs, or transcript analysis.
- Local decision data tags Nemotron-Labs-Diffusion 3B for Long context.
- ShieldGemma 9B has broader tracked provider coverage for fallback and procurement flexibility.
- Local decision data tags ShieldGemma 9B for Classification.
Monthly cost at traffic
Estimate token spend from the cheapest tracked input and output route or tier on this page.
Nemotron-Labs-Diffusion 3B
Unavailable
No complete token price in local provider data
ShieldGemma 9B
Unavailable
No complete token price in local provider data
Cost delta unavailable until both models have sourced input and output token prices.
Switch friction
- No overlapping tracked provider route is sourced for Nemotron-Labs-Diffusion 3B and ShieldGemma 9B; plan for SDK, billing, or endpoint changes.
- No overlapping tracked provider route is sourced for ShieldGemma 9B and Nemotron-Labs-Diffusion 3B; plan for SDK, billing, or endpoint changes.
Specs
| Specification | ||
|---|---|---|
| Released | 2026-05-23 | 2024-07-01 |
| Context window | 131k | 8k |
| Parameters | 3B | 9B |
| Architecture | Decoder Only | Decoder Only |
| License | NVIDIA Open Model | Gemma |
| Openness | Open weights | Open weights |
| Commercial use | Commercial use: permitted | Commercial use: conditional |
| Knowledge cutoff | - | - |
Pricing and availability
| Pricing attribute | Nemotron-Labs-Diffusion 3B | ShieldGemma 9B |
|---|---|---|
| Input price | - | - |
| Output price | - | - |
| Providers | - |
Pricing not yet sourced for either model.
Capabilities
| Capability | Nemotron-Labs-Diffusion 3B | ShieldGemma 9B |
|---|---|---|
| Vision | No | No |
| Multimodal | No | No |
| Reasoning | No | No |
| Function calling | No | No |
| Tool use | No | No |
| Structured outputs | No | No |
| Code execution | No | No |
| IDE integration | No | No |
| Computer use | No | No |
| Parallel agents | No | No |
Benchmarks
No shared benchmark scores are currently available for this pair.
Deep dive
The capability footprint is close: both models cover the core production surface. That makes context budget, benchmark fit, and provider maturity more important than a simple checklist. If your application depends on one integration detail, verify it against the provider route you plan to use, not just the base model listing.
Pricing coverage is uneven: Nemotron-Labs-Diffusion 3B has no token price sourced yet and ShieldGemma 9B has no token price sourced yet. Provider availability is 0 tracked routes versus 1. Treat unknown pricing as an integration gap, then verify the route you will actually call before estimating production spend.
Choose Nemotron-Labs-Diffusion 3B when long-context analysis and larger context windows are central to the workload. Choose ShieldGemma 9B when provider fit and broader provider choice are more important. For production, rerun your own prompts through the exact provider, region, and tool stack you plan to ship. This keeps the decision grounded in measurable tradeoffs instead of brand-level assumptions. It also helps separate model capability from provider packaging, which can change cost and latency. For teams standardizing a stack, that distinction is often the difference between a benchmark win and a reliable deployment.
FAQ
Which has a larger context window, Nemotron-Labs-Diffusion 3B or ShieldGemma 9B?
Nemotron-Labs-Diffusion 3B supports 131k tokens, while ShieldGemma 9B supports 8k tokens. That gap matters most for long documents, large codebases, retrieval-heavy agents, and conversations where earlier context must remain visible.
Is Nemotron-Labs-Diffusion 3B or ShieldGemma 9B open source?
Nemotron-Labs-Diffusion 3B is listed under NVIDIA Open Model. ShieldGemma 9B is listed under Gemma. License labels affect whether you can self-host, redistribute weights, or rely only on hosted APIs, so confirm the upstream license before deployment.
Where can I run Nemotron-Labs-Diffusion 3B and ShieldGemma 9B?
Nemotron-Labs-Diffusion 3B is available on the tracked providers still being sourced. ShieldGemma 9B is available on NVIDIA NIM. Provider coverage can affect latency, region availability, compliance posture, and fallback options.
When should I pick Nemotron-Labs-Diffusion 3B over ShieldGemma 9B?
Nemotron-Labs-Diffusion 3B fits 16x more tokens; pick it for long-context work and ShieldGemma 9B for tighter calls. If your workload also depends on long-context analysis, start with Nemotron-Labs-Diffusion 3B; if it depends on provider fit, run the same evaluation with ShieldGemma 9B.
Continue comparing
Last reviewed: 2026-06-20. Data sourced from public model cards and provider documentation.